Technip Energies BV (TE)
Euronext Paris · France · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 30.80 |
|---|---|
| 52-week range | 26.94 – 41.58 |
| Return, 1 month / 3 months | +3.3% / −9.4% |
| Return, 1 year / 3 years | −15.4% / +68.5% |
| Trend | Below its 200-day average |
| RSI (14) | 56 |
| Volatility (1 year) | 34.3% |
| Worst drawdown (1 year) | -29.9% |
| Average daily value traded | 12.62M EUR |
| Dividend yield | 3.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Technip Energies is an engineering and technology company based in Paris that designs and builds large energy and industrial facilities. It provides engineering, procurement, construction and project management services to clients in the liquefied natural gas, refining, petrochemical and low-carbon energy sectors. Its projects include gas processing plants, hydrogen and carbon capture installations, and other process facilities for energy companies and industrial operators around the world.
Technip Energies BV trades under the code TE on the Euronext Paris in France, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Technip Energies BV (TE) trades on the Euronext Paris in France. It last closed at EUR 30.80 on 23 October 2026.
Its price-based Market X-Ray is 54 out of 100 (a fair price profile), ranking 286 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 15.4% and over the last three months it fell 9.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 48 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -6.8% | ||
| From 52-week high | -25.1% | ||
| Momentum | 36 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -9.4% | ||
| 6-month return | -20.8% | ||
| 12-month return, skipping the last month | -18.1% | ||
| Stability (higher is calmer) | 60 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 34.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -29.9% | ||
| Liquidity | 91 · Strong | Trades actively. | |
| Average daily value traded | 12.62M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 48 · Weak | Dividend is small or irregular. | |
| Dividend yield | 3.2% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | −0.6% |
|---|---|
| 1 month | +3.3% |
| 3 months | −9.4% |
| 6 months | −20.8% |
| 1 year | −15.4% |
| 3 years | +68.5% |
| 5 years | +168.3% |
Signals
| 50-day / 200-day average | 29.73 / 33.05 |
|---|---|
| Golden / death cross (60 days) | Death, 58 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.91 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 18 May 2026 | EUR 1.0000 |
| 20 May 2025 | EUR 0.8500 |
| 21 May 2024 | EUR 0.5700 |
| 21 Feb 2024 | EUR 0.5700 |
| 22 May 2023 | EUR 0.5200 |
| 18 May 2022 | EUR 0.4500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.